• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Eugene E. Braunwald, Elliott M. Antman, +20 authors Sidney C. Smith
  • Medicine
  • Journal of the American College of Cardiology
  • 2002
  • Board of Trustees in March 2002 and by the American Heart Association Science Advisory and Coordinating Committee in March 2002. When citing this document, the American College of Cardiology and theContinue Reading
  • Laurent Bonello, Udaya S. Tantry, +18 authors Paul A Gurbel
  • Medicine
  • Journal of the American College of Cardiology
  • 2010 (First Publication: 1 September 2010)
  • The addition of clopidogrel to aspirin treatment reduces ischemic events in a wide range of patients with cardiovascular disease. However, recurrent ischemic event occurrence during dual antiplateletContinue Reading
  • Abraham Michael Lincoff, John A Bittl, +18 authors Eric J. Topol
  • Medicine
  • JAMA
  • 2003 (First Publication: 19 February 2003)
  • CONTEXT The direct thrombin inhibitor bivalirudin has been associated with better efficacy and less bleeding than heparin during coronary balloon angioplasty but has not been widely tested duringContinue Reading
  • Eugene E. Braunwald, Elliott M. Antman, +20 authors Sidney C. Smith
  • Medicine
  • Journal of the American College of Cardiology
  • 2000 (First Publication: 1 September 2000)
  • Preamble......971 I. Introduction ......972 A. Organization of Committee and Evidence Review......972 B. Purpose of These Guidelines......973 C. Overview of the Acute CoronaryContinue Reading
  • Paul A Gurbel, Kevin P. Bliden, +13 authors Robert F Storey
  • Medicine
  • Circulation
  • 2009 (First Publication: 18 November 2009)
  • BACKGROUND Ticagrelor is the first reversibly binding oral P2Y(12) receptor antagonist. This is the first study to compare the onset and offset of platelet inhibition (IPA) with ticagrelor using theContinue Reading